HSBC Holdings’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $115K | Buy |
98,491
+17,056
| +21% | +$20K | ﹤0.01% | 2351 |
|
|
2025
Q1 | $115K | Buy |
81,435
+12,280
| +18% | +$17.3K | ﹤0.01% | 2325 |
|
|
2024
Q4 | $147K | Buy |
69,155
+16,768
| +32% | +$35.6K | ﹤0.01% | 2383 |
|
|
2024
Q3 | $148K | Buy |
52,387
+7,723
| +17% | +$21.9K | ﹤0.01% | 2336 |
|
|
2024
Q2 | $103K | Sell |
44,664
-9,452
| -17% | -$21.9K | ﹤0.01% | 2356 |
|
|
2024
Q1 | $242K | Buy |
54,116
+9,452
| +21% | +$42.3K | ﹤0.01% | 2169 |
|
|
2023
Q4 | $142K | Buy |
44,664
+28,509
| +176% | +$90.8K | ﹤0.01% | 2069 |
|
|
2023
Q3 | $50.7K | Buy |
+16,155
| New | +$50.7K | ﹤0.01% | 2111 |
|
|
2022
Q3 | – | Sell |
-11,500
| Closed | -$131K | – | 2443 |
|
|
2022
Q2 | $131K | Sell |
11,500
-16,929
| -60% | -$193K | ﹤0.01% | 2557 |
|
|
2022
Q1 | $261K | Buy |
28,429
+11,680
| +70% | +$107K | ﹤0.01% | 2472 |
|
|
2021
Q4 | $251K | Sell |
16,749
-10,318
| -38% | -$155K | ﹤0.01% | 2424 |
|
|
2021
Q3 | $698K | Sell |
27,067
-15,393
| -36% | -$397K | ﹤0.01% | 1650 |
|
|
2021
Q2 | $1.11M | Buy |
42,460
+30,960
| +269% | +$810K | ﹤0.01% | 1369 |
|
|
2021
Q1 | $406K | Sell |
11,500
-4,110
| -26% | -$145K | ﹤0.01% | 1782 |
|
|
2020
Q4 | $395K | Sell |
15,610
-1,156
| -7% | -$29.3K | ﹤0.01% | 1946 |
|
|
2020
Q3 | $634K | Buy |
16,766
+5,266
| +46% | +$199K | ﹤0.01% | 1409 |
|
|
2020
Q2 | $492K | Sell |
11,500
-1,439
| -11% | -$61.6K | ﹤0.01% | 1500 |
|
|
2020
Q1 | $245K | Buy |
+12,939
| New | +$245K | ﹤0.01% | 1765 |
|